The FDA has cautioned that compounded products are risky for patients and that poor compounding practices can result in serious drug quality problems that can lead to serious patient injury and death. 19 Recent Issues with GLP-1 Compounders
But what you really want to know is when you will see results at each dose level
Gruszka MD, PhD, an independent medical writer, who wrote the paper on behalf of Springer Healthcare Italia, and Monica Tambalo, PhD, who created the figures using BioRender.com on behalf of Springer Healthcare Italia
We are also grateful to Carmen Guerrero for her experimental advice
New patients can access an introductory price of $199 per month for the first two months of treatment (available through March 31, 2026)
The AUC and C max ratios with or without SNAC administration remained within the 0.81.25 range